Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$18.99 -1.60 (-7.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Share-based Compensation (IS) (2014)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) posted Share-based Compensation (IS) of $689,000 for Q3 2014, down 76.0% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Share-based Compensation (IS) (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 689,000.00
Jun 30, 2014 2.88 Mn
API Access

Viridian Therapeutics, Inc.\DE Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=VRDN&period=max&api_key=YOUR_API_KEY